Symbols / CTXR $0.81 -6.24% Citius Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NCM
CTXR Chart
About

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 18.04M
Enterprise Value 26.73M Income -35.89M Sales 3.94M
Book/sh 3.57 Cash/sh 0.34 Dividend Yield —
Payout 0.00% Employees 23 IPO —
P/E — Forward P/E 0.29 PEG —
P/S 4.57 P/B 0.23 P/C —
EV/EBITDA -0.73 EV/Sales 6.78 Quick Ratio 0.31
Current Ratio 0.99 Debt/Eq 1.96 LT Debt/Eq —
EPS (ttm) -2.46 EPS next Y 2.79 EPS Growth —
Revenue Growth — Earnings 2026-05-13 ROA -17.68%
ROE -47.85% ROIC — Gross Margin 79.99%
Oper. Margin -214.14% Profit Margin 0.00% Shs Outstand 22.38M
Shs Float 21.88M Short Float 18.48% Short Ratio 5.47
Short Interest — 52W High 2.48 52W Low 0.63
Beta 1.38 Avg Volume 557.35K Volume 200.13K
Target Price $6.00 Recom None Prev Close $0.86
Price $0.81 Change -6.24%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$0.80
Latest analyst target
3. DCF / Fair value
$-32.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.80
Low
$6.00
High
$6.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-11 main D. Boral Capital Buy → Buy $6
2025-12-04 main D. Boral Capital Buy → Buy $6
2025-08-13 main D. Boral Capital Buy → Buy $6
2025-06-30 main D. Boral Capital Buy → Buy $6
2025-06-10 main D. Boral Capital Buy → Buy $6
2025-06-09 main D. Boral Capital Buy → Buy $9
2025-05-23 down Maxim Group Buy → Hold —
2025-05-15 main D. Boral Capital Buy → Buy $9
2025-02-18 main D. Boral Capital Buy → Buy $9
2025-01-07 main D. Boral Capital Buy → Buy $9
2024-12-30 up D. Boral Capital Hold → Buy $9
2024-11-22 down D. Boral Capital Buy → Hold —
2024-11-12 reit HC Wainwright & Co. Buy → Buy $4
2024-11-11 main D. Boral Capital Buy → Buy $6
2024-08-19 main EF Hutton Buy → Buy $6
2024-08-08 main EF Hutton Buy → Buy $6
2024-08-05 main EF Hutton Buy → Buy $6
2024-07-15 init EF Hutton — → Buy $6
2024-05-31 reit HC Wainwright & Co. Buy → Buy $4
2024-02-14 reit HC Wainwright & Co. Buy → Buy $4
News
RSS: Latest CTXR news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
38.53
-8.26%
42.00
+14.33%
36.73
+10.25%
33.32
Research And Development
9.16
-23.10%
11.91
-19.66%
14.82
-16.06%
17.66
Selling General And Administration
29.37
-2.39%
30.09
+37.32%
21.91
+39.92%
15.66
General And Administrative Expense
29.37
-2.39%
30.09
+37.32%
21.91
+39.92%
15.66
Salaries And Wages
10.84
-8.47%
11.84
+78.94%
6.62
+69.40%
3.91
Other Gand A
18.53
+1.55%
18.25
+19.31%
15.30
+30.12%
11.75
Total Expenses
38.53
-8.26%
42.00
+14.33%
36.73
+10.25%
33.32
Operating Income
-38.53
+8.26%
-42.00
-14.33%
-36.73
-10.25%
-33.32
Total Operating Income As Reported
-38.53
+8.26%
-42.00
-14.33%
-36.73
-10.25%
-33.32
EBITDA
-38.20
+8.58%
-41.79
-14.36%
-36.54
-10.26%
-33.14
Normalized EBITDA
-38.20
+8.58%
-41.79
-14.36%
-36.54
-10.26%
-33.14
Reconciled Depreciation
0.21
+2.21%
0.21
+7.87%
0.19
+8.15%
0.18
EBIT
-38.42
+8.53%
-42.00
-14.33%
-36.73
-10.25%
-33.32
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-37.43
+4.36%
-39.14
-20.27%
-32.54
+3.26%
-33.64
Pretax Income
-38.68
+0.43%
-38.85
-21.53%
-31.97
+3.32%
-33.06
Net Non Operating Interest Income Expense
-0.16
-120.80%
0.76
-35.73%
1.18
+369.14%
0.25
Interest Expense Non Operating
0.27
—
—
0.00
Net Interest Income
-0.16
-120.80%
0.76
-35.73%
1.18
+369.14%
0.25
Interest Expense
0.27
—
—
0.00
Interest Income Non Operating
0.11
-85.48%
0.76
-35.73%
1.18
+369.14%
0.25
Interest Income
0.11
-85.48%
0.76
-35.73%
1.18
+369.14%
0.25
Other Income Expense
—
2.39
-33.41%
3.59
—
Other Non Operating Income Expenses
—
2.39
-33.41%
3.59
—
Tax Provision
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-39.74
-0.80%
-39.43
-21.15%
-32.54
+3.26%
-33.64
Net Income From Continuing Operation Net Minority Interest
-37.43
+4.36%
-39.14
-20.27%
-32.54
+3.26%
-33.64
Net Income From Continuing And Discontinued Operation
-37.43
+4.36%
-39.14
-20.27%
-32.54
+3.26%
-33.64
Net Income Continuous Operations
-39.74
-0.80%
-39.43
-21.15%
-32.54
+3.26%
-33.64
Minority Interests
2.31
+703.61%
0.29
0.00
—
Normalized Income
-37.43
+4.36%
-39.14
-20.27%
-32.54
+3.26%
-33.64
Net Income Common Stockholders
-37.43
+6.85%
-40.19
-19.27%
-33.69
-0.16%
-33.64
Otherunder Preferred Stock Dividend
0.00
-100.00%
1.05
-9.02%
1.15
0.00
Diluted EPS
-3.38
+43.38%
-5.97
-7.18%
-5.57
+3.13%
-5.75
Basic EPS
-3.38
+43.38%
-5.97
-7.18%
-5.57
+3.13%
-5.75
Basic Average Shares
11.07
+64.49%
6.73
+11.16%
6.05
+3.57%
5.84
Diluted Average Shares
11.07
+64.49%
6.73
+11.16%
6.05
+3.57%
5.84
Diluted NI Availto Com Stockholders
-37.43
+6.85%
-40.19
-19.27%
-33.69
-0.16%
-33.64
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
130.94
+12.25%
116.65
+12.59%
103.61
-9.11%
114.00
Current Assets
27.93
+96.44%
14.22
-58.63%
34.37
-22.87%
44.56
Cash Cash Equivalents And Short Term Investments
4.25
+30.76%
3.25
-87.72%
26.48
-36.51%
41.71
Cash And Cash Equivalents
4.25
+30.76%
3.25
-87.72%
26.48
-36.51%
41.71
Inventory
22.29
+169.53%
8.27
0.00
—
Work In Process
11.71
+448.71%
2.13
—
—
Finished Goods
10.58
+72.42%
6.13
—
—
Prepaid Assets
1.40
-48.32%
2.70
-65.78%
7.89
+176.57%
2.85
Total Non Current Assets
103.00
+0.56%
102.43
+47.93%
69.24
-0.28%
69.44
Net PPE
0.82
+232.47%
0.25
-45.98%
0.46
-29.89%
0.65
Gross PPE
0.82
+232.47%
0.25
-45.98%
0.46
-29.89%
0.65
Other Properties
0.82
+232.47%
0.25
-45.98%
0.46
-29.89%
0.65
Goodwill And Other Intangible Assets
102.15
+0.00%
102.15
+48.58%
68.75
+0.00%
68.75
Goodwill
9.35
+0.00%
9.35
+0.00%
9.35
+0.00%
9.35
Other Intangible Assets
92.80
+0.00%
92.80
+56.23%
59.40
+0.00%
59.40
Non Current Prepaid Assets
0.04
+0.00%
0.04
+0.00%
0.04
+0.00%
0.04
Total Liabilities Net Minority Interest
53.41
+25.52%
42.55
+249.35%
12.18
+15.20%
10.57
Current Liabilities
44.91
+25.41%
35.81
+519.74%
5.78
+27.57%
4.53
Payables And Accrued Expenses
40.53
+21.56%
33.34
+879.67%
3.40
+32.40%
2.57
Payables
36.34
+9.05%
33.33
+1038.48%
2.93
+151.19%
1.17
Accounts Payable
13.69
+177.92%
4.93
+68.32%
2.93
+151.19%
1.17
Other Payable
22.65
-20.25%
28.40
—
—
Current Accrued Expenses
4.19
+24509.46%
0.02
-96.43%
0.48
-66.11%
1.41
Pensionand Other Post Retirement Benefit Plans Current
3.29
+47.71%
2.23
+3.34%
2.16
+22.40%
1.76
Current Debt And Capital Lease Obligation
1.09
+350.57%
0.24
+10.61%
0.22
+10.86%
0.20
Current Debt
1.00
—
—
—
Current Capital Lease Obligation
0.09
-63.42%
0.24
+10.61%
0.22
+10.86%
0.20
Total Non Current Liabilities Net Minority Interest
8.50
+26.14%
6.74
+5.23%
6.40
+5.92%
6.04
Long Term Debt And Capital Lease Obligation
0.72
+3300.53%
0.02
-91.89%
0.26
-45.38%
0.48
Long Term Capital Lease Obligation
0.72
+3300.53%
0.02
-91.89%
0.26
-45.38%
0.48
Non Current Deferred Liabilities
7.77
+15.74%
6.71
+9.38%
6.14
+10.36%
5.56
Non Current Deferred Taxes Liabilities
7.77
+15.74%
6.71
+9.38%
6.14
+10.36%
5.56
Stockholders Equity
67.55
-3.61%
70.08
-22.85%
90.83
-11.67%
102.83
Common Stock Equity
67.55
-3.61%
70.08
-22.85%
90.83
-11.67%
102.83
Capital Stock
0.02
+149.32%
0.01
+14.05%
0.01
-95.65%
0.15
Common Stock
0.02
+149.32%
0.01
+14.05%
0.01
-95.65%
0.15
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
18.07
+149.31%
7.25
+14.05%
6.35
+8.65%
5.85
Ordinary Shares Number
18.07
+149.31%
7.25
+14.05%
6.35
+8.65%
5.85
Additional Paid In Capital
306.34
+12.86%
271.44
+7.26%
253.06
+8.90%
232.37
Retained Earnings
-238.80
-18.59%
-201.37
-24.13%
-162.23
-25.09%
-129.69
Minority Interest
9.98
+147.92%
4.02
+570.31%
0.60
+0.00%
0.60
Total Equity Gross Minority Interest
77.53
+4.62%
74.10
-18.95%
91.43
-11.60%
103.43
Total Capitalization
67.55
-3.61%
70.08
-22.85%
90.83
-11.67%
102.83
Working Capital
-16.98
+21.37%
-21.59
-175.53%
28.59
-28.58%
40.03
Invested Capital
68.55
-2.18%
70.08
-22.85%
90.83
-11.67%
102.83
Total Debt
1.81
+589.81%
0.26
-45.38%
0.48
-29.04%
0.68
Capital Lease Obligations
0.81
+209.39%
0.26
-45.38%
0.48
-29.04%
0.68
Net Tangible Assets
-34.60
-7.88%
-32.07
-245.21%
22.08
-35.20%
34.08
Tangible Book Value
-34.60
-7.88%
-32.07
-245.21%
22.08
-35.20%
34.08
Current Notes Payable
1.00
—
—
—
Interest Payable
—
—
—
—
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-26.55
+5.85%
-28.20
+2.96%
-29.06
-2.46%
-28.36
Cash Flow From Continuing Operating Activities
-26.55
+5.85%
-28.20
+2.96%
-29.06
-2.46%
-28.36
Net Income From Continuing Operations
-39.74
-0.80%
-39.43
-21.15%
-32.54
+3.26%
-33.64
Depreciation Amortization Depletion
0.21
+2.21%
0.21
+7.87%
0.19
+8.15%
0.18
Depreciation
0.21
+2.21%
0.21
+7.87%
0.19
+8.15%
0.18
Depreciation And Amortization
0.21
+2.21%
0.21
+7.87%
0.19
+8.15%
0.18
Other Non Cash Items
0.03
-90.64%
0.28
+178.60%
0.10
-73.03%
0.38
Stock Based Compensation
10.84
-8.47%
11.84
+78.94%
6.62
+69.40%
3.91
Deferred Tax
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Deferred Income Tax
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Operating Gains Losses
—
—
—
—
Change In Working Capital
1.05
+162.52%
-1.69
+57.94%
-4.01
-1772.40%
0.24
Change In Inventory
-12.65
-492.78%
-2.13
0.00
—
Change In Prepaid Assets
-0.06
+93.21%
-0.95
+81.23%
-5.04
-4430.59%
-0.11
Change In Payables And Accrued Expense
12.94
+739.91%
1.54
+84.98%
0.83
+23.99%
0.67
Change In Accrued Expense
4.17
+1008.66%
-0.46
+50.57%
-0.93
-218.59%
0.78
Change In Payable
8.77
+338.35%
2.00
+13.50%
1.76
+1677.16%
-0.11
Change In Account Payable
8.77
+338.35%
2.00
+13.50%
1.76
+1677.16%
-0.11
Change In Other Working Capital
1.06
+1376.27%
0.07
-81.75%
0.39
+374.60%
-0.14
Change In Other Current Liabilities
-0.24
-8.20%
-0.22
-10.86%
-0.20
-11.14%
-0.18
Investing Cash Flow
-5.75
-15.00%
-5.00
0.00
0.00
Cash Flow From Continuing Investing Activities
-5.75
-15.00%
-5.00
0.00
0.00
Net PPE Purchase And Sale
—
—
—
0.00
Purchase Of PPE
—
—
—
0.00
Capital Expenditure
—
—
—
—
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Net Other Investing Changes
-5.75
-15.00%
-5.00
—
—
Financing Cash Flow
33.30
+233.96%
9.97
-27.89%
13.83
0.00
Cash Flow From Continuing Financing Activities
33.30
+233.96%
9.97
-27.89%
13.83
0.00
Net Issuance Payments Of Debt
1.30
0.00
—
0.00
Issuance Of Debt
1.30
0.00
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Short Term Debt Issuance
1.30
0.00
—
—
Net Short Term Debt Issuance
1.30
0.00
—
—
Net Common Stock Issuance
32.30
+134.02%
13.80
+0.04%
13.80
0.00
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.03
0.00
Net Other Financing Charges
-0.30
+92.17%
-3.83
—
—
Changes In Cash
1.00
+104.31%
-23.23
-52.51%
-15.23
+46.30%
-28.36
Beginning Cash Position
3.25
-87.72%
26.48
-36.51%
41.71
-40.47%
70.07
End Cash Position
4.25
+30.76%
3.25
-87.72%
26.48
-36.51%
41.71
Free Cash Flow
-26.55
+5.85%
-28.20
+2.96%
-29.06
-2.46%
-28.36
Interest Paid Supplemental Data
0.19
0.00
—
—
Change In Interest Payable
—
—
—
0.00
Common Stock Issuance
32.30
+134.02%
13.80
+0.04%
13.80
0.00
Issuance Of Capital Stock
32.30
+134.02%
13.80
+0.04%
13.80
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category